Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model

Effective therapeutic strategies for triple-negative breast cancer (TNBC) are still lacking. Clinical data suggest that a large number of TNBC patients cannot benefit from single immune checkpoint inhibitor (ICI) treatment due to the immunosuppressive tumour microenvironment (TME). Therefore, combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huan, Xie, Weimin, Zhang, Yuning, Dong, Xiwen, Liu, Chao, Yi, Jing, Zhang, Shun, Wen, Chunkai, Zheng, Li, Wang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113929/
https://www.ncbi.nlm.nih.gov/pubmed/34561555
http://dx.doi.org/10.1038/s41417-021-00389-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113929/
https://www.ncbi.nlm.nih.gov/pubmed/34561555
http://dx.doi.org/10.1038/s41417-021-00389-3

Ejemplares similares